Immunity Passports will negatively impact the prow and disadvantaged in our communities. Can we afford this now?. Too many lives have already been lost.
Outside the pandemic, “investigational” remains payer code for denying reimbursement. In the case of treatment for chronic conditions, even FDA-approved digital-health and connected devices languish on waitlists for formulary inclusion.